Iris de Nie

165 A PORTFOLIO I de Nie , A Meißner, EH Kostelijk, AT Soufan, IAC Voorn-de Warem, M den Heijer, J Huirne, NM van Mello. Impaired semen quality in trans women: prevalence and determinants. Human Reproduction. Volume 35, Issue 7, July 2020, Pages 1529–1536. Presentations at (international) conferences and symposia 2021 Reflecting on the importance of family building and fertility preservation: transgender people’s experiences with starting medical treatment as adolescent. Oral presentation as part of Symposium ‘Evaluation of early medical treatment for gender dysphoria in adolescence: a long term follow-up study into adulthood’. European Professional Association for Transgender Health (EPATH), Götenborg, Sweden. A prospective cohort study on factors impairing semen quality in transgender women. Oral presentation. European Professional Association for Transgender Health (EPATH), Götenborg, Sweden. Tight undergarment and tucking impair semen quality: a prospective cohort study in trans women . Poster presentation and pitch. European Association of Urology (EAU), Virtual conference. 2020 Influence of transgender specific factors on semen quality. Oral presentation. World Professional Association for Transgender Health (WPATH), Virtual conference. Prostate cancer incidence under androgen deprivation: a nationwide cohort study in trans women receiving hormone treatment. Poster presentation. European Association of Urology (EAU), Virtual conference. Impaired semen quality in trans women: prevalence and determinants. Poster presentation. European Association of Urology (EAU), Virtual conference. Prostate cancer incidence under androgen deprivation: a nationwide cohort study in trans women receiving hormone treatment. Oral presentation. Dutch Endocrine Meeting (DEM), Noordwijkerhout, The Netherlands. 2019 Impaired semen quality in trans women: prevalence and determinants. Poster presentation. International Society for Fertility Preservation (ISFP), New York, United States of America. The incidence of prostate cancer in transwomen receiving hormonal treatment. Oral presentation. European Professional Association for Transgender Health (EPATH), Rome, Italy. Prostate cancer risk in trans women receiving hormonal treatment. Oral presentation. Research Institute AG&M PhD retreat, Putten, The Netherlands.